Status:
UNKNOWN
Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer
Lead Sponsor:
Chung-Ang University
Conditions:
Sentinel Lymph Node Biopsy
Colon Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The technique of sentinel lymph node mapping in patients with colon cancer varies among reports, and the optimal method remain to be established. The purpose of this study was to determine the optimal...
Eligibility Criteria
Inclusion
- Stage I - III colon cancer patients
Exclusion
- cancer located at the low rectum which were located within 10 cm of the dentate, recurrent or metastatic colon carcinoma, adjacent organ invasion tumor, prior chemotherapy or radiation, cancer with intestinal obstruction, past intestinal surgery
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00654342
Start Date
October 1 2007
Last Update
April 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Chung-Ang university Hospital
Seoul, South Korea, 156-755